000 01609 a2200457 4500
005 20250518042307.0
264 0 _c20200724
008 202007s 0 0 eng d
022 _a2051-1426
024 7 _a10.1186/s40425-019-0614-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChandramohan, Vidyalakshmi
245 0 0 _aImproved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations.
_h[electronic resource]
260 _bJournal for immunotherapy of cancer
_c05 2019
300 _a142 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aBrain Neoplasms
_xdrug therapy
650 0 4 _aCell Line, Tumor
650 0 4 _aDisease Models, Animal
650 0 4 _aErbB Receptors
_xpharmacology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunotoxins
_xdrug effects
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
700 1 _aBao, Xuhui
700 1 _aYu, Xin
700 1 _aParker, Scott
700 1 _aMcDowall, Charlotte
700 1 _aYu, Yen-Rei
700 1 _aHealy, Patrick
700 1 _aDesjardins, Annick
700 1 _aGunn, Michael D
700 1 _aGromeier, Matthias
700 1 _aNair, Smita K
700 1 _aPastan, Ira H
700 1 _aBigner, Darell D
773 0 _tJournal for immunotherapy of cancer
_gvol. 7
_gno. 1
_gp. 142
856 4 0 _uhttps://doi.org/10.1186/s40425-019-0614-0
_zAvailable from publisher's website
999 _c29742920
_d29742920